Glycemic Legacy: The Importance of Early Glycemic Control

To begin the course, please login or register by clicking ENROLL. After logging in, you will be able to complete the pretest and view the video/documents. You will have the option to complete the posttest, evaluation and receive credit. Some courses may have an associated cost.

Step Status
Video/Document(s)
Posttest
Evaluation
Starts On: 11/22/2024: 12:00 AM
Ends On: 6/30/2025: 12:00 AM
Session Type: Internet Activity Enduring Material
Credits: 0.5
Description: Glycemic Legacy: The Importance of Early Glycemic Control was part of the 51st Annual Washington University Kilo Diabetes Symposium which was developed and implemented inter-professionally by physicians, nurses and pharmacists. This day and a half in-person symposium is designed for adult and pediatric endocrinologists, internists, hospitalists, family & general practice physicians, nurses, pharmacists, but may be of interest to nurse practitioners, physician assistants and certified diabetic educators and other health care professionals who care for patients with diabetes. The agenda will focus on the following areas: Endocrinology Updates; Diabetes Technology; TYPE 2 Diabetes; Revisited; Diabetes Complications; GLP1 Update and Inpatient Diabetes. This activity will provide education through lectures, demonstrations, case presentations and questions & answers. This course intends to provide practical and state-of-the-art information about the diagnosis and management of diabetes and common endocrine disorders that can be implemented across specialties. Diabetes and endocrine diseases require a multi-disciplinary approach for optimal management this activity is designed with a multi-disciplinary faculty from Washington University School of Medicine and Barnes Jewish Hospital. The intended goal of this activity is increased knowledge, competence and performance and enhanced patient care.
Objectives: The intended goal of this activity is increased knowledge, competence and performance and enhanced patient care.
Additional Information: The original day and a half in-person symposium was designed for adult and pediatric endocrinologists, internists, hospitalists, family & general practice physicians, nurses, pharmacists, but may be of interest to nurse practitioners, physician assistants and certified diabetic educators and other health care professionals who care for patients with diabetes.
Accreditation Information:
wustlcme
In support of improving patient care, this activity has been planned and implemented by Encompass Health Corporation and Washington University School of Medicine in St. Louis. Washington University School of Medicine in St Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Awarded for this Activity:

Credit Statement:
American Medical Association (AMA Credit)
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC Credit)
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of 0.5 ANCC contact hour.
Interprofessional Continuing Education (IPCE)
This activity was planned by and for the healthcare team, and learners will receive 0.5 Interprofessional Continuing Education (IPCE) credits for learning and change.

Disclosure Information: It is the policy of Washington University School of Medicine in St. Louis, Continuing Medical Education, to ensure balance, independence, objectivity and scientific rigor in all its educational activities. All planners, faculty and other persons who may influence content of this CME activity have disclosed all relevant financial relationships commercial interests. All disclosures have been reported and are indicated with their presentations. Any potential conflicts were addressed and mitigated.
All members of the CME department have nothing to disclose.
Speakers are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.
Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients. All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis.
These presentations are not an endorsement of any commercial interests.
These presentations are the views and experiences of the presenters. The presenters' views do not represent the policy or position of Washington University School of Medicine in St. Louis. Washington University School of Medicine in St. Louis, Continuing Medical Education is the provider for CME credits.
  • This course is intended for healthcare professionals only.
  • Continuing Medical Education at Washington University School of Medicine fully complies with the legal requirements of the Americans with Disabilities Act rules and regulations thereof. If any participant of this course is in need of accommodations, please contact us at cme@wustl.edu.
  • Contact : Matt King - matt.king@wustl.edu 

    Speaker

    Janet B. McGill, MD, MA, FACP, Professor of Medicine, Washington University
    Category: Didactic presentations with dedicated Q&A time, Handouts, Other, Panel

    Accreditation

    AMA: 0.50
    ANCC: 0.50
    Attendance: 0.50
    IPCE: 0.50


    Powered By AI 4.5